An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

Tanvir Huda; Harish Nair; Evropi Theodoratou; Lina Zgaga; Ali Fattom; Shams El Arifeen; Craig Rubens; Harry Campbell; Igor Rudan

doi:10.1186/1471-2458-11-S3-S27

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

Tanvir Huda, Harish Nair, Evropi Theodoratou, Lina Zgaga, Ali Fattom, Shams El Arifeen, Craig Rubens, Harry Campbell, Igor Rudan

Deanery of Clinical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.

Original language	English
Pages (from-to)	S27
Journal	BMC Public Health
Volume	11 Suppl 3
DOIs	https://doi.org/10.1186/1471-2458-11-S3-S27
Publication status	Published - 2011

Access to Document

10.1186/1471-2458-11-S3-S27

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children
© 2011 Huda et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Final published version, 428 KBLicence: Creative Commons: Attribution (CC-BY)

http://www.biomedcentral.com/1471-2458/11/S3/S27

Fingerprint Dive into the research topics of 'An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children'. Together they form a unique fingerprint.

Cite this

@article{e24ec33edf5b40e584c4c4f0ec1dd294,

title = "An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children",

abstract = "Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.",

author = "Tanvir Huda and Harish Nair and Evropi Theodoratou and Lina Zgaga and Ali Fattom and {El Arifeen}, Shams and Craig Rubens and Harry Campbell and Igor Rudan",

year = "2011",

doi = "10.1186/1471-2458-11-S3-S27",

language = "English",

volume = "11 Suppl 3",

pages = "S27",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central",

}

TY - JOUR

T1 - An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

AU - Huda, Tanvir

AU - Nair, Harish

AU - Theodoratou, Evropi

AU - Zgaga, Lina

AU - Fattom, Ali

AU - El Arifeen, Shams

AU - Rubens, Craig

AU - Campbell, Harry

AU - Rudan, Igor

PY - 2011

Y1 - 2011

N2 - Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.

AB - Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.

U2 - 10.1186/1471-2458-11-S3-S27

DO - 10.1186/1471-2458-11-S3-S27

M3 - Article

C2 - 21501445

VL - 11 Suppl 3

SP - S27

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

ER -